Home
About Us
Research Projects
Research Staff
Career Opportunities
Contact Us
Employee Advisories
ONTT Publications

  1. Beck RW, Optic Neuritis Study Group. The Optic Neuritis Treatment Trial.
    Arch Ophthalmol 1988; 106:1051-53.

  2. Optic Neuritis Study Group. The clinical profile of acute optic neuritis:
    Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 1991;
    109:1673-78.

  3. Beck RW, Cleary PA, Anderson MM, et al. A randomized, controlled trial of
    corticosteroids in the treatment of acute optic neuritis. New Eng J Med 1992;
    326:581-88.

  4. Beck RW, Kupersmith MJ, Cleary PA, Katz B, Optic Neuritis Study Group.
    Fellow Eye Abnormalities in Acute Unilateral Optic Neuritis: Experience of the
    Optic Neuritis Treatment Trial. Ophthalmology 1993; 100:691-98.

  5. Keltner JL, Johnson CA, Spurr JO, Beck RW, Optic Neuritis Study Group.
    Baseline Visual Field Profile of Optic Neuritis: The Experience of the Optic
    Neuritis Treatment Trial. Arch Ophthalmol 1993; 111:231-34.

  6. Beck RW, Arrington J, Murtagh FR, Cleary PA, Kaufman DI, Optic Neuritis
    Study Group. Brain MRI In Acute Optic Neuritis: Experience of the Optic
    Neuritis Study Group. Arch Neurol 1993; 50:841-846.

  7. Cleary PA, Beck RW, Anderson MM, Kenny DJ, Backlund J, Gilbert PR, Optic
    Neuritis Study Group. Design, Methods, and Conduct of the Optic Neuritis
    Treatment Trial. Controlled Clinical Trials 1993; 14:123-42.

  8. Keltner JL, Johnson CA, Beck RW, Cleary PA, Spurr JO, Optic Neuritis Study
    Group. Quality Control Functions of the Visual Field Reading Center (VFRC) For
    The Optic Neuritis Treatment Trial (ONTT). Controlled Clinical Trials 1993;
    14:143-59.

  9. Beck RW, Cleary PA, Optic Neuritis Study Group. Recovery from Severe
    Visual Loss in Optic Neuritis. Arch Ophthalmol 1993; 111:300.

  10. Beck RW, Diehl L, Cleary PA, and the Optic Neuritis Study Group. The
    Pelli-Robson Letter Chart: Normative Data For Young Adults. Clinical Vision
    Science 1993; 8:207-10.

  11. Chrousos GA, Kattah JC, Beck RW, Cleary PA, Optic Neuritis Study Group.
    Side effects of glucocorticoid treatment: experience of the Optic Neuritis
    Treatment Trial. JAMA 1993; 269:2110-12.

  12. Beck RW, Cleary PA, and the Optic Neuritis Study Group. Optic Neuritis
    Treatment Trial: One-year follow-up results. Arch Ophthalmol 1993; 111:
    773-775.

  13. Beck RW, Cleary PA, Trobe JD, Kaufman DI, Kupersmith MJ, Paty DW, Brown CH,
    and the Optic Neuritis Study Group. The effect of corticosteroids for acute
    optic neuritis on the subsequent development of multiple sclerosis. New Eng J
    Med 1993; 329:1764-69.

  14. Keltner JL, Johnson CA, Spurr JO, Beck RW, for the Optic Neuritis Study
    Group. Visual field profile of optic neuritis: one-year follow-up in the Optic
    Neuritis Treatment Trial. Arch Ophthalmol 1994; 112: 946-953.

  15. Beck RW, Cleary PA, Backlund JC, the Optic Neuritis Study Group. The
    course of visual recovery after optic neuritis: Experience of the Optic
    Neuritis Treatment Trial. Ophthalmology 1994; 101:1771-1778.

  16. Beck RW, for the Optic Neuritis Study Group. The Optic Neuritis Treatment
    Trial: Three-year follow-up results. Arch Ophthalmol 1995; 113:136-37.

  17. Anderson MM, Boly LD, Beck RW, for the Optic Neuritis Study Group. Remote
    Clinic/Patient monitoring for multicenter trials. Controlled Clinical Trials
    1996; 17:407-414.

  18. Beck RW, Trobe JD, for the Optic Neuritis Study Group. The Optic Neuritis
    Treatment Trial: putting the results in perspective. J Neuro-ophthalmol 1995;
    15:131-35.

  19. Beck RW, Trobe JD, for the Optic Neuritis Study Group. What we have
    learned from the Optic Neuritis Treatment Trial. Ophthalmology 1995;
    102:1504-08.

  20. Rolak LA, Beck RW, Paty DW, Tourtellotte WW, Whitaker JN, Rudick RA, for
    the Optic Neuritis Study Group. Cerebrospinal fluid in acute optic neuritis:
    experience of the Optic Neuritis Treatment Trial. Neurology 1996;46:368-72.

  21. Trobe JD, Beck RW, Moke PS, Cleary PA. Contrast Sensitivity and Other
    Vision Tests in The Optic Neuritis Treatment Trial. Am J Ophthalmol 1996; 121:
    547-53.

  22. Cleary PA, Beck RW, Bourque LB, Backlund JC, Miskala PH. Visual symptoms
    after optic neuritis. Results from the Optic Neuritis Treatment Trial. J
    Neuro-ophthalmol 1997;17:18-28.

  23. Optic Neuritis Study Group. The five year risk of multiple sclerosis after
    optic neuritis. Experience of the Optic Neuritis Treatment Trial. Neurology
    1997; 49:1404-1413.

  24. Optic Neuritis Study Group. Visual function five years after optic
    neuritis. Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol
    1997; 115:1545-52.

  25. Cole, SR, Beck RW, Moke, PS, Kaufman DI, Tourtellotte WW, for the Optic
    Neuritis Study Group. The predictive value of CSF oligoclonal banding for MS 5
    years after optic neuritis. Neurology 1998; 51:885-887.